<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article-commentary" dtd-version="1.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="issn">1043-3155</journal-id>
<journal-id journal-id-type="nlm-ta">Pediatr Neurol Briefs</journal-id>
<journal-id journal-id-type="pmc">pedneurbriefs</journal-id>
<journal-id journal-id-type="iso-abbrev">Pediatr Neurol Briefs</journal-id>
<journal-title-group>
<journal-title>Pediatric Neurology Briefs</journal-title>
<abbrev-journal-title>Pediatr Neurol Briefs</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2166-6482</issn>
<issn pub-type="ppub">1043-3155</issn>
<issn-l>2166-3155</issn-l>
<publisher>
<publisher-name>Pediatric Neurology Briefs Publishers</publisher-name>
<publisher-loc>Chicago, IL, USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PNB-6-46</article-id>
<article-id pub-id-type="doi">10.15844/pedneurbriefs-6-6-9</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Toxic Disorders</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v2">
<subject>Neurology</subject>
<subject>Pediatrics</subject>
<subject>Nervous System Diseases</subject>
<subject>Child Development</subject>
<subject>Brain Diseases</subject>
<subject>Neurosurgery</subject>
<subject>Child</subject>
<subject>Infant</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Aspartame and Absence Seizures</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0173-7931</contrib-id>
<name>
<surname>Millichap</surname>
<given-names>J. Gordon</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="AF0001">1</xref>
<xref ref-type="aff" rid="AF0002">2</xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
</contrib-group>
<aff id="AF0001">
<label>1</label>Division of Neurology, Children&#x0027;s Memorial Hospital, Chicago, IL</aff>
<aff id="AF0002">
<label>2</label>Departments of Pediatrics and Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL</aff>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label>Correspondence: Dr. J. Gordon Millichap, E-mail: <email xlink:href="jgmillichap@northwestern.edu">jgmillichap@northwestern.edu</email>
</corresp>
</author-notes>
<pub-date date-type="pub" publication-format="print">
<month>06</month>
<year>1992</year>
</pub-date>
<pub-date date-type="pub" publication-format="electronic">
<day>01</day>
<month>07</month>
<year>2016</year>
</pub-date>
<volume>6</volume>
<issue>6</issue>
<fpage>46</fpage>
<lpage>47</lpage>
<permissions>
<copyright-statement>Copyright: &#x00A9; 1992 The Author(s)</copyright-statement>
<copyright-year>1992</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This work is licensed under the <uri xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International License</uri>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<related-article id="R1" related-article-type="commentary-article" ext-link-type="doi" xlink:href="10.1212/WNL.42.5.1000" vol="42" page="1000">
<article-title>Aspartame exacerbates EEG spike-wave discharge in children with generalized absence epilepsy: a double-blind controlled study</article-title>
</related-article>
<abstract abstract-type="web-summary" specific-use="electronic-only">
<p>The effect of aspartame on epilepsy was studied in 10 children with previously untreated generalized absence seizures using a double blind challenge of 40 mg/kg aspartame as a single dose at the Children&#x2019;s Hospital, Halifax, Canada.</p>
</abstract>
<kwd-group>
<kwd>Aspartame</kwd>
<kwd>Absence Seizures</kwd>
<kwd>Neuropsychiatry Problems</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>The effect of aspartame on epilepsy was studied in 10 children with previously untreated generalized absence seizures using a double blind challenge of 40 mg/kg aspartame as a single dose at the Children&#x2019;s Hospital, Halifax, Canada. Ambulatory cassette recording of the EEG and quantification of numbers and length of spike wave discharges on 2 consecutive days showed that the number of seconds spent in spike wave discharge per hour of recording was significantly increased following aspartame compared with the control day when the children received sucrose. [<xref ref-type="bibr" rid="CIT0001">1</xref>]</p>
<disp-quote>
<p><bold>COMMENT.</bold> Anecdotal claims that aspartame may exacerbate epilepsy appear to have scientific validity based on this EEG double blind controlled study in 10 children with absence seizures.</p>
<p>In support of the FDA decision to clear aspartame for general consumption, excepting phenylketonuric children, a study of 126 apparently healthy children and adolescents showed that there were no clinically significant differences documented between the children taking aspartame and those taking sucrose for a 13 week period, regardless of age between 2 and 21 years. Aspartame appeared to be a safe sweetening agent for use by healthy children aged 2 or older [<xref ref-type="bibr" rid="CIT0002">2</xref>]. However, studies of aspartame in children with neuropsychiatric problems are limited, and adequate data are not available to establish its safety and freedom from adverse effects. Until more specific investigations are completed to determine the effects of aspartame on seizure control it might be advisable to limit or avoid the ingestion of aspartame products in children with seizures and particularly poorly controlled absence seizures (Camfield et al. 1992). See Millichap JG. [<xref ref-type="bibr" rid="CIT0003">3</xref>] for a review of the effects of aspartame on diseases of the nervous system in children.</p>
</disp-quote>
</body>
<back>
<ref-list>
<ref id="CIT0001">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Camfield</surname>
<given-names>PR</given-names>
</name>
<name>
<surname>Camfield</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Dooley</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Jollymore</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Weaver</surname>
<given-names>DF</given-names>
</name>
</person-group>
<article-title>Aspartame exacerbates EEG spike-wave discharge in children with generalized absence epilepsy: a double-blind controlled study</article-title>
<source>Neurology</source>
<year>1992</year>
<month>May</month>
<volume>42</volume>
<issue>5</issue>
<fpage>1000</fpage>
<lpage>1003</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.42.5.1000</pub-id>
<pub-id pub-id-type="pmid">1579221</pub-id>
</element-citation>
</ref>
<ref id="CIT0002">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frey</surname>
<given-names>GH</given-names>
</name>
</person-group>
<article-title>Use of aspartame by apparently healthy children and adolescents</article-title>
<source>J Toxicology Environmental Health</source>
<year>1976</year>
<month>Nov</month>
<volume>2</volume>
<issue>2</issue>
<fpage>401</fpage>
<lpage>415</lpage>
<pub-id pub-id-type="doi">10.1080/15287397609529442</pub-id>
<pub-id pub-id-type="pmid">137987</pub-id>
</element-citation>
</ref>
<ref id="CIT0003">
<label>3</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Millichap</surname>
<given-names>JG</given-names>
</name>
</person-group>
<source>Nutrition Diet and Child&#x2019;s Behavior</source>
<year>1986</year>
<publisher-loc>Springfield</publisher-loc>
<publisher-name>Charles C. Thomas</publisher-name>
</element-citation>
</ref>
</ref-list>
</back>
</article>